Several bills have been introduced in the United States to address trade relations with China, including one that withdraws normal trade relations treatment, The Closing Loopholes for the Overseas Use and Development of Artificial Intelligence Act, and The Pharmaceuticals Supply Chain Security Act. Other bills aim to address trade agreements with Taiwan, CTPAT, shipping evaluations, and intellectual property rights.